PGNY
Progyny, Inc. · Healthcare · Medical - Healthcare Plans
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 71.83K | $1.90M | n/a | n/a |
| Q2 2026 | 111 | +7 | 55.02M | $1.59B | +10 | −2 |
| Q1 2026 | 106 | -1 | 57.93M | $989.34M | +8 | −10 |
| Q4 2025 | 108 | +1 | 64.14M | $1.65B | +4 | −2 |
| Q3 2025 | 20 | 0 | 47.53M | $1.02B | +1 | −2 |
| Q2 2025 | 18 | +2 | 41.38M | $910.37M | +2 | n/a |
| Q1 2025 | 13 | +1 | 12.87M | $287.47M | +2 | −1 |
| Q4 2024 | 12 | +3 | 10.40M | $179.35M | +3 | n/a |
| Q3 2024 | 8 | -3 | 5.55M | $93.05M | +1 | −4 |
| Q2 2024 | 11 | n/a | 4.74M | $135.69M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 2.03M | n/a | $57.99M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Baillie Gifford ✦ | 871.00K | n/a | $24.92M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 3 | Millennium Management ✦ | 535.96K | n/a | $15.33M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 413.66K | n/a | $11.83M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 5 | Point72 Asset Management ✦ | 240.82K | n/a | $6.89M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 208.61K | n/a | $5.97M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Norges Bank ✦ (passive) | 204.03K | n/a | $5.84M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 154.10K | n/a | $4.41M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 58.82K | n/a | $1.68M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 21.15K | n/a | $595,288 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Gotham Asset Management ✦ | 7.87K | n/a | $225,075 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 283 holders, 69.63M shares, $1.17B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.88K sh · $52,612
Officer · 3.90K sh · $101,868
Director · 11.50K sh · $321,358
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology